Protagonist Therapeutics (PTGX)
(Delayed Data from NSDQ)
$38.25 USD
+2.15 (5.96%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $38.22 -0.03 (-0.08%) 5:12 PM ET
2-Buy of 5 2
D Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.50 | 0.00% |
Earnings Summary
For their last quarter, Protagonist Therapeutics (PTGX) reported earnings of $3.26 per share, beating the Zacks Consensus Estimate of $2.51 per share. This reflects a positive earnings surprise of 29.88%. Look out for PTGX's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.50 per share, reflecting a year-over-year increase of 26.47%.
Earnings History
Price & Consensus
Zacks News for PTGX
All You Need to Know About Protagonist Therapeutics (PTGX) Rating Upgrade to Buy
PTGX: What are Zacks experts saying now?
Zacks Private Portfolio Services